BNR
Burning Rock Biotech Limited$9.07
LiveJun 08, 2026
Market cap
$9.64M
52w range
2.95 – 41.72
P / E
—
EPS
—
Volume
17.97K
Revenue · FY
—
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
| In USD | CAGR |
|---|---|
| Top-line | |
| Revenue · YoY | — |
| Gross profit · YoY | — |
| Profit | |
| Operating income · YoY | — |
| EBITDA · YoY | — |
| Net income · YoY | — |
| Operating | |
| EBIT · YoY | — |
| R&D · YoY | — |
| Per-share | |
| EPS · diluted · YoY | — |
| EPS · basic · YoY | — |
Sourced from key_metrics + financial_ratios (loaded by load_fundamentals_extended.py).
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| P / E | — | — |
| P / B | — | — |
| EV / EBITDA | — | — |
| EV / Sales | -0.53x | 0.08x |
| Earnings yield | -36.4% | -68.4% |
| FCF yield | -22.2% | -19.4% |
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Gross margin | — | — |
| Operating margin | — | — |
| Net margin | — | — |
| ROE | -10.3% | -59.7% |
| ROA | -6.7% | -39.2% |
| ROIC | -9.3% | -55.6% |
| Metric | FY 2025 | FY 2024 |
|---|---|---|
| Debt / equity | — | — |
| Net debt / EBITDA | 13.70 | 1.73 |
| Interest coverage | — | — |
| Current ratio | 2.99x | 2.92x |
| Quick ratio | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).